Correction to: Cell Death and Disease
https://doi.org/10.1038/s41419-018-0865-6, published online 24 July 2018
On Pubmed, the name of co-author Roger Olofsson Bagge appeared incorrectly as “Bagge RO” instead of “Olofsson Bagge, Roger”.
This has been corrected in the PDF and HTML versions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Einarsdottir, B.O., Karlsson, J., Söderberg, E.M.V. et al. Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma. Cell Death Dis 11, 99 (2020). https://doi.org/10.1038/s41419-020-2301-y
Published:
Version of record:
DOI: https://doi.org/10.1038/s41419-020-2301-y
